Erratum: Radiation dosimetry of N-([11C]methyl)benperidol as determined by whole-body PET imaging of primates (European Journal of Nuclear Medicine and Molecular Imaging DOI: 10.1007/s00259-007-0644-6);Radiation dosimetry of N-([11C]methyl)benperidol as determined by whole-body PET imaging of primates

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 4, 2008, Pages 771-778

  Antenor Dorsey, Jo Ann V ^a   Laforest, Richard ^a   Moerlein, Stephen M ^a   Videen, Tom O ^a   Perlmutter, Joel S ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Campus Box 8225 ^*  (United States)

Author keywords

D2 like receptor; Radiation dosimetry; Radioligand; 11C NMB

Indexed keywords

CARBON 11; DOPAMINE 2 RECEPTOR; N METHYLBENPERIDOL C 11; RADIOLIGAND; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BABOON; BLADDER; BLOOD; BRAIN; CORPUS STRIATUM; DOSE RESPONSE; DOSIMETRY; DRUG ABSORPTION; DRUG DISTRIBUTION; EYE; FEMALE; HEAD; HEART; HEART MUSCLE; IN VIVO STUDY; KIDNEY; LARGE INTESTINE; LIVER; LUNG; MALE; NONHUMAN; PARAMETER; PELVIS; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; RADIATION EXPOSURE; RECEPTOR BINDING; TIME ACTIVITY CURVE; VOLUME OF INTEREST; WHOLE BODY IMAGING;

EID: 40949123481     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-013-2356-4     Document Type: Erratum

References (25)

1. Antonini A, Schwarz J, Oertel WH, Pogarell O, Leenders KL. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride. Mov Disord 1997;12:33-8.
2. Perlmutter JS, Stambuk MK, Markham J, Black KJ, McGee-Minnich L, Jankovic J, et al. Decreased [18F] spiperone binding in putamen in idiopathic focal dystonia. J Neurosci 1997;17:843-50.
3. Wong DF, Singer HS, Brandt J, Shaya E, Chen C, Brown J, et al. D2-like dopamine receptor density in Tourette's syndrome measured by PET. J Nucl Med 1997;38:1243-7.
4. Vernaleken I, Siessmeier T, Buchholz HG, Hartter S, Hiemke C, Stoeter P, et al. High striatal occupancy of D2-like dopamine receptors by amisulpride in the brain of patients with schizophrenia. Int J Neuropsychopharmacol 2004;7:421-30.
5. 3H-N-methylspiperone to dopamine and serotonin receptors. Life Sci 1987;40:987-95.
6. 18F]fluoro-ethyl)spiperone in baboon brain. Eur J Nucl Med 1988;14:80-7.
7. Perlmutter JS, Moerlein SM, Hwang DR, Todd RD. Non-steady-state measurement of in vivo radioligand binding with positron emission tomography: specificity analysis and comparison with in vitro binding. J Neurosci 1991;11:1381-9.
8. 3H]raclopride: implications for positron emission tomography of the human brain. Synapse 1992;3:96-7.
9. 11C-raclopride is altered by drugs that modify synaptic dopamine level. Synapse 1993;13:350-6.
10. 18F]fallypride in striatum and extrastriatal regions in humans. Neuropsychopharma 2006;31:1016-26.
11. 11C]methyl)benperidol for PET investigation of D2 receptor binding. Radiochem Acta 2004;92:333-9.
12. Mazoyer B, Trebossen R, Deutch R, Casey M, Blohn K. Physical characteristics of the ECAT 953B/31: a new high-resolution brain positron tomograph. IEEE Trans Med Imaging 1991;10:499-504.
13. Spinks TJ, Jones T, Bailey DL, Townsend DW, Grootoonk S, Bloomfield PM, et al. Physical performance of positron tomograph for brain imaging with retractable septa. Phys Med Biol 1992;37:1637-55.
14. Olinger JM. Model-based scatter correction for fully 3D PET. Phys Med Biol 1996;41:153-76.
15. Mahaney MC, Leland MM, Williams-Blangero S, Martinez YN. Cross-sectional growth standards for captive baboons: I. Organ weight by body weight. J Med Primatol 1993;22:415-27.
16. Snyder WS, Fisher HL Jr., Ford MR, Warner GG. Estimates of absorbed fractions for monoenergetic photon sources uniformly distributed in various organs of a heterogeneous phantom. J Nucl Med 1969;10(S3):5-12.
17. Snyder WS, Ford MR, Warner GG, Watson SB. "S," absorbed dose per unit cumulated activity for selected radionuclides and organs. MIRD Pamphlet no. 11. New York: Society of Nuclear Medicine; 1975.
18. Anderson CJ, Dehdashti F, Cutler PD, Schwarz SW, Laforest R, Bass LA, et al. 64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors. J Nucl Med 2001;42:213-21.
19. Wessels BW, Bolch WE, Bouchet LG, Breitz HB, DeNardo GL, Meredith RF, et al. Bone marrow dosimetry using blood-based models for radiolabeled antibody therapy: a multi-institutional comparison. J Nucl Med 2004;45:1725-33.
20. Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 2005;46:1023-7.
21. 2-like receptor binding. J Cereb Blood Flow Metab 1997;17:833-45.
22. Soudijn W, van Wijngaarden I, Allewijn F. Distribution, excretion and metabolism of neuroleptics of the butyrophenone type. Eur J Pharmacol 1967;1:47-57.
23. Goldberg LI. Dopamine receptors and hypertension. Physiologic and pharmacologic implications. Am J Med 1984;77:37-44.
24. Saji H, Yonekura Y, Tanahashi K, Iida Y, Iwasaki Y, Magata Y, et al. Myocardial accumulation of a dopamine D2 receptor-binding radioligand, 2′-iodospiperone. Ann Nucl Med 1993;7:153-6.
25. 18F](N-methyl)benperidol as determined by whole-body pet imaging of primates. Nucl Med Biol 1997;24:311-8.